Literature DB >> 6128200

Effect of route administration and liposome entrapment on the metabolism and disposition of adriamycin in the rat.

R J Parker, E R Priester, S M Sieber.   

Abstract

The plasma clearance, tissue distribution, metabolism, and excretion of free Adriamycin (Adr) and liposome-entrapped Adr (Adr/L) was examined after iv and ip administration to rats. When given iv, free Adr was cleared more rapidly from plasma than was Adr/L. In contrast, Adr and Adr/L were cleared from plasma at similar rates when given by the ip route and peak plasma concentrations were significantly lower than observed after iv treatment. Irrespective of the route of administration, tissue distribution of Adr was altered after liposome entrapment, with increased uptake of Adr equivalents into liver and spleen and decreased uptake into kidney, heart, and lung. However, tissue concentrations of Adr were generally lower in rats treated ip with Adr or Adr/L than in animals dosed iv. Furthermore, an enhanced uptake of Adr/L relative to free Adr in lymph nodes draining the peritoneal cavity was observed only in animals treated by the ip route. The rates of both biliary and urinary excretion of Adr were 1/3-1/2 of control after liposome entrapment regardless of the route of administration, although excretion rates in rats dosed ip were half of those observed in animals treated by the iv route. Similarly, liposome entrapment of bromosulfophthalein was found to decrease its biliary excretion rate to 1/3-1/2 of control. Bile and urine of rats given Adr/L iv contained a higher proportion of Adr metabolites and less unchanged Adr than was found in animals receiving the free drug. This finding suggests that liposome entrapment of Adr leads to a modification in the metabolism of this drug in rats.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6128200

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  5 in total

1.  Lymphatic transport of liposome-encapsulated drugs following intraperitoneal administration - effect of lipid composition.

Authors:  K Hirano; C A Hunt; A Strubbe; R D Macgregor
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

Review 2.  Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies.

Authors:  Yumei Xie; Taryn R Bagby; M S Cohen; M Laird Forrest
Journal:  Expert Opin Drug Deliv       Date:  2009-08       Impact factor: 6.648

3.  Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats.

Authors:  Peng Zou; Lawrence Helson; Anirban Maitra; Stephan T Stern; Scott E McNeil
Journal:  Mol Pharm       Date:  2013-04-22       Impact factor: 4.939

Review 4.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

5.  Disposition of 14C-labelled 4'-epidoxorubicin and doxorubicin in the rat. A comparative study.

Authors:  F Arcamone; M Lazzati; G P Vicario; G Zini
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.